Predictive Markers of Glofitamab Resistance in R/R B-NHL
Sep 3, 2026 - 15:41
Radio and PodcastLive Radio & PodcastsScience & Medicine
Treating AML, Before and After Relapse
In this episode, Blood editor Dr. Laura Michaelis interviews Drs. Nigel Russell and Uwe Platzbecker on their articles published in volume 147 issue 10 of Blood . Dr. Russell discuses " CPX-351 vs daunorubicin, cytarabine...
Related Episodes
Continue listening to more episodes from Blood Podcast.
FLT3-ITD microclones in AML and Results from the RESET-PV trial
Jul 30, 2026 - 13:48
Initial CHORUS data on HHT and ASH HematOmics Program
Jul 23, 2026 - 26:14
IV Iron during Acute Infection and Revisiting iTTP Refractoriness
Jul 16, 2026 - 16:45